Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06185621

The Effect of Aspirin on Recurrent Acute Pancreatitis

The Effect of 100mg Aspirin on Recurrent Acute Pancreatitis: a Prospective Cohort Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
23 (estimated)
Sponsor
Air Force Military Medical University, China · Academic / Other
Sex
All
Age
14 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Recurrent acute pancreatitis (RAP) was defined as two or more occurrences of acute pancreatitis, which was associated with higher percentages of morbidities and mortalities, lower patients' life quality and increased health-care costs. Current interventions, including cholecystectomy and abstain from drinking were reported to be effective methods for preventing the recurrences of biliary and alcoholic etiologies, respectively. However, there were no effective preventions for other etiologies, such as idiopathic etiologies. Non-steroid anti-inflammatory drugs (NSAIDs), including indomethacin, diclofenac and aspirin could inhibiting the inflammatory cascade of pancreatitis. In this study, we aimed at exploring the effects of 100mg aspirin on reducing the occurrences of recurrent acute pancreatitis.

Conditions

Interventions

TypeNameDescription
DRUG100mg aspirinPatients received oral 100mg aspirin, one tablet daily for 2 years

Timeline

Start date
2023-11-01
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2023-12-29
Last updated
2023-12-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06185621. Inclusion in this directory is not an endorsement.